- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Parker University
Total 225213 results
-
Dana-Farber Cancer InstituteBayerWithdrawn
-
University Medical Center GroningenNationaal Fonds tegen KankerNot yet recruitingSurgery | Perioperative Care | Prehabilitation | Exercise PrehabilitationNetherlands
-
University of Southern CaliforniaDana-Farber Cancer InstituteCompletedHigh Intensity Interval Training | Overweight and Obesity | Cognition | Metabolic DiseaseUnited States
-
University Hospital, AntwerpKom Op Tegen Kanker; AnticancerfundActive, not recruiting
-
Rockefeller UniversityClinical Directors Network; Carter Burden NetworkCompleted
-
Professor Lorraine HarperWellcome TrustUnknownANCA Associated Vasculitis | CMV InfectionUnited Kingdom
-
Dana-Farber Cancer InstituteNovartisRecruitingProstate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate CancerUnited States
-
Dana-Farber Cancer InstitutePfizerRecruiting
-
Dana-Farber Cancer InstitutePfizerRecruitingBladder Cancer | Muscle Invasive Bladder CancerUnited States
-
Dana-Farber Cancer InstitutePfizerRecruitingPancreatic Cancer | Solid Tumors | Lung Cancer Squamous Cell | Head & Neck CancerUnited States
-
Dana-Farber Cancer InstituteMedtronicActive, not recruiting
-
Whitman-Walker InstituteViiV HealthcareEnrolling by invitation
-
Dana-Farber Cancer InstitutePfizerActive, not recruitingBreast CancerUnited States
-
Dana-Farber Cancer InstituteCelgeneActive, not recruitingLangerhans Cell Histiocytosis (LCH) | Histiocytoses Erdheim-chester Disease | Histiocytic Sarcoma (HS)United States
-
Dana-Farber Cancer InstituteNovartisActive, not recruitingAcute Lymphoblastic Leukemia ALLUnited States
-
Dana-Farber Cancer InstituteAstraZenecaWithdrawnUveal Melanoma | Cutaneous Melanoma | Mucosal Melanoma | Recurrent Metastatic MelanomaUnited States
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Dana-Farber Cancer InstituteNovartisCompletedEverolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL (CRAD001NUS175T)Acute Lymphoblastic LeukemiaUnited States
-
Dana-Farber Cancer InstituteExelixisTerminatedSkin Cancer | Merkel Cell CarcinomaUnited States
-
Dana-Farber Cancer InstituteNovartisActive, not recruiting
-
Dana-Farber Cancer InstitutePfizerCompletedBreast Cancer Stage IV | Unresectable Locally Advanced Invasive Breast Cancer | Metastatic Invasive Breast CancerUnited States
-
Dana-Farber Cancer InstituteAbbVieCompletedWaldenstrom MacroglobulinemiaUnited States
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Dana-Farber Cancer InstituteAmgenTerminatedLymphoma | Autonomic Imbalance | Cancer SurvivorshipUnited States
-
Dana-Farber Cancer InstituteAllerganTerminatedPancreatic CancerUnited States
-
Dana-Farber Cancer InstituteBiogenCompletedGraft Versus Host DiseaseUnited States
-
Dana-Farber Cancer InstituteBayerWithdrawn
-
Memorial Sloan Kettering Cancer CenterDana-Farber Cancer Institute:Dana- Farber/Children's HospitalActive, not recruitingRelapsed B-Cell Acute Lymphoblastic LeukemiaUnited States
-
Parke-DavisCompletedHIV InfectionsUnited States
-
Eliz ArterCyprus Science UniversityCompleted
-
Maastricht University Medical CenterNationaal Fonds tegen KankerNot yet recruitingBreast Cancer | Breast Neoplasms
-
Alison WalkerCompletedRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
Rush University Medical CenterElsa U. Pardee FoundationTerminatedDiffuse Large B-Cell LymphomaUnited States
-
Dana-Farber Cancer InstituteBeiGeneRecruitingChronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma (SLL)United States
-
Dana-Farber Cancer InstituteAbbVieRecruitingB-Cell Lymphoma | B-cell Acute Lymphoblastic Leukemia | ALLUnited States
-
Dana-Farber Cancer InstituteAstraZenecaRecruiting
-
Dana-Farber Cancer InstituteAbbVieRecruiting
-
Dana-Farber Cancer InstituteAstraZenecaWithdrawnChronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Dana-Farber Cancer InstituteServierActive, not recruitingAcute Lymphoblastic Leukemia, PediatricUnited States, Canada
-
Dana-Farber Cancer InstitutePfizerActive, not recruiting
-
Dana-Farber Cancer InstitutePfizerCompleted
-
Dana-Farber Cancer InstituteBayerTerminatedSolid Tumor | Hand-Foot Skin Reaction (HFSR)United States
-
Dana-Farber Cancer InstituteAstraZenecaSuspendedMesotheliomaUnited States
-
The Cleveland ClinicFarmer FoundationCompletedHealthy | Parkinson Disease | Essential Tremor | DBSUnited States
-
Dana-Farber Cancer InstituteAstraZenecaActive, not recruitingUterine CancerUnited States
-
Dana-Farber Cancer InstituteAstraZenecaCompletedMuscle Invasive Bladder CancerUnited States
-
Dana-Farber Cancer InstituteSanofiCompletedGastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Small Bowel CancerUnited States
-
Dana-Farber Cancer InstituteNovartisTerminatedMetastatic Hormone-Receptor-Positive (HR+) Breast Cancer | HER2-Negative Breast Cancer | Metastatic Epithelial Ovarian CancerUnited States
-
Dana-Farber Cancer InstituteSanofiCompletedProstate CancerUnited States